Brevan Howard Capital Management LP Blueprint Medicines Corp Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 17,751 shares of BPMC stock, worth $1.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,751
Previous 11,957
48.46%
Holding current value
$1.5 Million
Previous $1.11 Million
40.09%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BPMC
# of Institutions
382Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$574 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$563 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$481 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$212 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$165 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.06B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...